Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Bafaloukos

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Melanoma Research|October 1, 2004
The role of taxanes in the treatment of metastatic melanomaHelen Gogas, Dimitrios Bafaloukos, Agop Y Bedikian
Vaccines|March 30, 2023
Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future ProspectsDimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, et al.
Clinics in Dermatology|April 24, 2013
Antiangiogenic and antiapoptotic treatment in advanced melanomaVasiliki Nikolaou, Alexander Stratigos, Dimitrios Bafaloukos, et al.
Vaccines|September 27, 2025
Individualized mRNA Vaccines in Melanoma-Where Do We Stand?Ioanna Gazouli, Dimitrios Bafaloukos, Christos Koutserimpas, et al.
Cancers|February 25, 2023
Evolving Treatment Landscape of <i>HER2</i>-mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and BeyondIoannis A Vathiotis, Dimitrios Bafaloukos, Konstantinos N Syrigos, et al.
Nature Reviews. Clinical Oncology|June 2, 2009
Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLCHelena Linardou, Issa J Dahabreh, Dimitrios Bafaloukos, et al.
Cureus|January 15, 2024
Bilateral Spontaneous Supraspinatus Tendon Rupture Under Prolonged BRAF/MEK Targeting Treatment in a Melanoma PatientDimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancerIssa J Dahabreh, Helena Linardou, Fotios Siannis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: an analytical databaseSamuel Murray, Issa J Dahabreh, Helena Linardou, et al.
Vaccines|April 23, 2022
Therapeutic Effect of mRNA SARS-CoV-2 Vaccine on Melanoma Skin MetastasesDimitrios Bafaloukos, Kalliopi Petraki, Aikaterini Bousmpoukea, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Melanoma Research|October 1, 2004
The role of taxanes in the treatment of metastatic melanomaHelen Gogas, Dimitrios Bafaloukos, Agop Y Bedikian
Vaccines|March 30, 2023
Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future ProspectsDimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, et al.
Clinics in Dermatology|April 24, 2013
Antiangiogenic and antiapoptotic treatment in advanced melanomaVasiliki Nikolaou, Alexander Stratigos, Dimitrios Bafaloukos, et al.
Vaccines|September 27, 2025
Individualized mRNA Vaccines in Melanoma-Where Do We Stand?Ioanna Gazouli, Dimitrios Bafaloukos, Christos Koutserimpas, et al.
Cancers|February 25, 2023
Evolving Treatment Landscape of <i>HER2</i>-mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and BeyondIoannis A Vathiotis, Dimitrios Bafaloukos, Konstantinos N Syrigos, et al.
Nature Reviews. Clinical Oncology|June 2, 2009
Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLCHelena Linardou, Issa J Dahabreh, Dimitrios Bafaloukos, et al.
Cureus|January 15, 2024
Bilateral Spontaneous Supraspinatus Tendon Rupture Under Prolonged BRAF/MEK Targeting Treatment in a Melanoma PatientDimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancerIssa J Dahabreh, Helena Linardou, Fotios Siannis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: an analytical databaseSamuel Murray, Issa J Dahabreh, Helena Linardou, et al.
Vaccines|April 23, 2022
Therapeutic Effect of mRNA SARS-CoV-2 Vaccine on Melanoma Skin MetastasesDimitrios Bafaloukos, Kalliopi Petraki, Aikaterini Bousmpoukea, et al.
Pageof 11